SCHEMBL23488442

SCHEMBL23488442

CO[C@@H]1O[C@H](COC(=O)c2cccc(OCc3ccccc3)c2C)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYMP P19971 1/20 0.49
LGALS8 O00214 1/20 0.43
PTGER1 P34995 1/20 0.43
SLC5A1 P13866 4/20 0.42
SLC5A2 P31639 4/20 0.42
MAPT P10636 3/20 0.42
L3MBTL1 Q9Y468 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
MAPK1 P28482 1/20 0.42
HTT P42858 1/20 0.42
PPIA P62937 1/20 0.40
EDNRA P25101 1/20 0.40
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
LGALS9 O00182 1/20 0.39
LGALS1 P09382 1/20 0.39
LGALS3 P17931 1/20 0.39
LGALS7; LGALS7B P47929 1/20 0.39
SLC6A2 P23975 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488274 0.83 TDP1 (0.49) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488550 0.82 MAOB (0.43) TYMPLGALS8SLC5A1SLC5A2L3MBTL1
SCHEMBL23488464 0.82 MAOB (0.43) TYMPLGALS8SLC5A1SLC5A2L3MBTL1
SCHEMBL23488630 0.82 XDH (0.48) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488472 0.82 MAOB (0.43) TYMPLGALS8SLC5A1SLC5A2L3MBTL1
SCHEMBL23488404 0.81 TYMP (0.42) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488529 0.81 LGALS8 (0.40) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488668 0.80 CHRNB2 (0.51) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488128 0.80 CHRNB2 (0.51) TYMPLGALS8SLC5A1SLC5A2TDP1
SCHEMBL23488262 0.80 CHRNB2 (0.51) TYMPLGALS8SLC5A1SLC5A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TYMP 2235/4885LGALS8 61/4885PTGER1 4792/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.